New York, July 01, 2024 (GLOBE NEWSWIRE) -- The Global size is expected to reach by 2024 and it is further anticipated to reach a market value of by 2033, at a CAGR of from 2024 to 2033. The orthopedic regenerative surgical products market is vital in healthcare, focusing on developing and distributing regenerative technologies for orthopedic surgeries. It includes diverse components like biological implants, cell therapies, platelet-rich plasma, and advanced regenerative medicine.
Key drivers of this market include musculoskeletal disorder prevalence, aging population, regenerative medicine advancements, and demand for minimally invasive procedures. Based on the product, Visco supplements are projected to hold of the market share in 2024, dominate the orthopedic regenerative surgical products market due to their non-invasive nature, providing effective pain relief and quick recovery. Cost-effectiveness, versatility, and continuous research efforts further solidify their position.
The market's evolution depends on ongoing advancements in regenerative medicine. In the context of application, Cartilage and tendon repair, are anticipated to hold of the market share in 2024, dominate the orthopedic regenerative surgical products market. This dominance is driven by the prevalence of musculoskeletal conditions and advancements in regenerative medicine, the market addresses joint injuries, aging-related disorders, and chronic conditions, emphasizing targeted, non-invasive solutions.
.
